Skip to main content

Table 6

From: Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer

Surgical morbidity

Mean

Range

Surgical time

6.3

4.3–8

Bleeding

1860 mL

600–1600

Units transfused

3.4

1–6

Hospital stay

11-7

6–41

Intensive Care Unit stay

1.8

0–12

   Complication (events)

  

Intestinal occlusion

1 (11%)

 

Massive bleeding

1 (11%)

 

Urinary fistula

1 (11%)

 

Perineal infection

2 (22%)

 

Death

1 (11%)*

 
  1. The patient died (fistula and infection) at 4 months post-exenteration. This patient had pathological complete response.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us